A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions
Atopic Dermatitis
What is the purpose of this trial?
This is an observational study to assess the long-term safety of Protopic® Ointment for the treatment of atopic dermatitis. Patients whose ages are/were < 16 years at the time of first tacrolimus ointment exposure are eligible to participate. No drug is distributed during this observational trial.
Participation Guidelines
- Age:
- Up to 16 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Astellas Pharma Inc
- Dates:
- May 2005
- Last Updated:
- March 31, 2011
- Study HIC#:
- 0506000135
Clinicaltrials.gov ID: NCT00475605


